Targeting biomolecular condensation and protein aggregation against cancer
Biomolecular condensates, membrane-less entities arising from liquid–liquid phase
separation, hold dichotomous roles in health and disease. Alongside their physiological …
separation, hold dichotomous roles in health and disease. Alongside their physiological …
Inhibition of p53 protein aggregation as a cancer treatment strategy
K Kwan, O Castro-Sandoval, C Gaiddon… - Current Opinion in …, 2023 - Elsevier
The p53 protein plays a critical role in the prevention of genome mutations in the body,
however, this protein is frequently mutated in cancer and almost all cancers exhibit …
however, this protein is frequently mutated in cancer and almost all cancers exhibit …
Treating p53 mutant aggregation-associated cancer
M Kanapathipillai - Cancers, 2018 - mdpi.com
p53 is a tumor suppressor protein. Under stressful conditions, p53 tightly regulates cell
growth by promoting apoptosis and DNA repair. When p53 becomes mutated, it loses its …
growth by promoting apoptosis and DNA repair. When p53 becomes mutated, it loses its …
Targeting the prion-like aggregation of mutant p53 to combat cancer
Conspectus Prion-like behavior of several amyloidogenic proteins has been demonstrated
in recent years. Despite having functional roles in some cases, irregular aggregation can …
in recent years. Despite having functional roles in some cases, irregular aggregation can …
Aberrant phase separation and cancer
K Taniue, N Akimitsu - The FEBS journal, 2022 - Wiley Online Library
Eukaryotic cells are intracellularly divided into numerous compartments or organelles, which
coordinate specific molecules and biological reactions. Membrane‐bound organelles are …
coordinate specific molecules and biological reactions. Membrane‐bound organelles are …
Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands
EC Petronilho, MM Pedrote, MA Marques… - Chemical …, 2021 - pubs.rsc.org
Mutant p53 tends to form aggregates with amyloid properties, especially amyloid oligomers
inside the nucleus, which are believed to cause oncogenic gain-of-function (GoF). The …
inside the nucleus, which are believed to cause oncogenic gain-of-function (GoF). The …
Biomolecular condensates and their links to cancer progression
Liquid–liquid phase separation (LLPS) has emerged in recent years as an important
physicochemical process for organizing diverse processes within cells via the formation of …
physicochemical process for organizing diverse processes within cells via the formation of …
A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer
JJ Miller, C Gaiddon, T Storr - Chemical Society Reviews, 2020 - pubs.rsc.org
Referred to as the “guardian of the genome”, p53 is the most frequently mutated protein in
cancer and almost all cancers exhibit malfunction along the p53 pathway. As an …
cancer and almost all cancers exhibit malfunction along the p53 pathway. As an …
Mesoscopic protein-rich clusters host the nucleation of mutant p53 amyloid fibrils
The protein p53 is a crucial tumor suppressor, often called “the guardian of the genome”;
however, mutations transform p53 into a powerful cancer promoter. The oncogenic capacity …
however, mutations transform p53 into a powerful cancer promoter. The oncogenic capacity …
Intrinsically disordered proteins and biomolecular condensates as drug targets
M Biesaga, M Frigolé-Vivas, X Salvatella - Current Opinion in Chemical …, 2021 - Elsevier
Intrinsically disordered domains represent attractive therapeutic targets because they play
key roles in cancer, as well as in neurodegenerative and infectious diseases. They are …
key roles in cancer, as well as in neurodegenerative and infectious diseases. They are …